ATE472329T1 - Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis - Google Patents

Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis

Info

Publication number
ATE472329T1
ATE472329T1 AT03755551T AT03755551T ATE472329T1 AT E472329 T1 ATE472329 T1 AT E472329T1 AT 03755551 T AT03755551 T AT 03755551T AT 03755551 T AT03755551 T AT 03755551T AT E472329 T1 ATE472329 T1 AT E472329T1
Authority
AT
Austria
Prior art keywords
ciclesonide
combination
anthistaminics
treatment
allergic rhinitis
Prior art date
Application number
AT03755551T
Other languages
English (en)
Inventor
Degenhard Marx
Helgert Mueller
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of ATE472329T1 publication Critical patent/ATE472329T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03755551T 2002-08-30 2003-08-29 Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis ATE472329T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02019406 2002-08-30
PCT/EP2003/009622 WO2004019955A1 (en) 2002-08-30 2003-08-29 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
ATE472329T1 true ATE472329T1 (de) 2010-07-15

Family

ID=31970274

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03755551T ATE472329T1 (de) 2002-08-30 2003-08-29 Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis

Country Status (21)

Country Link
US (2) US7879832B2 (de)
EP (2) EP1545548B1 (de)
JP (2) JP4746318B2 (de)
KR (1) KR101067795B1 (de)
CN (1) CN1674916A (de)
AT (1) ATE472329T1 (de)
AU (1) AU2003273396B2 (de)
BR (2) BR0313611A (de)
CA (1) CA2495830C (de)
DE (1) DE60333205D1 (de)
DK (1) DK1545548T3 (de)
ES (2) ES2393864T3 (de)
IL (1) IL166483A (de)
MX (1) MXPA05001885A (de)
NO (1) NO335400B1 (de)
NZ (1) NZ538954A (de)
PL (1) PL373433A1 (de)
PT (1) PT1545548E (de)
SI (1) SI1545548T1 (de)
WO (1) WO2004019955A1 (de)
ZA (1) ZA200500719B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
ES2312844T3 (es) * 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
AU2004246819A1 (en) * 2003-06-13 2004-12-23 Nycomed Gmbh Formoterol and ciclesonide combination
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
KR100878698B1 (ko) * 2007-04-05 2009-01-13 한미약품 주식회사 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
CN103260623B (zh) * 2010-10-06 2016-11-02 伊斯塔制药公司 贝托斯汀组合物
JP5683719B2 (ja) * 2011-01-04 2015-03-11 イスタ・ファーマシューティカルズ・インコーポレイテッドＩｓｔａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． ベポタスチン組成物
EP2968323A4 (de) 2013-03-13 2016-12-14 Flatley Discovery Lab Pyridazinonverbindungen und verfahren zur behandlung von zystischer fibrose
CN106692115A (zh) * 2015-11-13 2017-05-24 天津金耀集团有限公司 一种环索奈德混悬鼻喷剂组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (de) 1963-04-24
US3813384A (en) 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4369184A (en) 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
ATE84968T1 (de) * 1987-11-13 1993-02-15 Asta Medica Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
CZ287877B6 (cs) 1993-04-02 2001-03-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Prednisolonové deriváty a farmaceutické prostředky s jejich obsahem
EP0709099A3 (de) 1994-09-28 1996-07-24 Senju Pharma Co Wässrige Suspension zur nasalen Verabreichung enthaltend Cyclodextrin
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
AU6290396A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
EP0780127A1 (de) 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin
CA2256721A1 (en) 1996-06-04 1997-12-11 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
IL131492A0 (en) 1997-04-30 2001-01-28 Warner Lambert Co Topical nasal antiinflammatory compositions
EP0903151A1 (de) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Verwendung von Kombinationen enthaltend nichtsedierende Antihistaminika und Alfa-Adrenergische Agonisten für die topische Behandlung von Rhinitis/Konjunktivitis sowie Erkältungs- und Grippe-Symptomen
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6297227B1 (en) * 1998-09-10 2001-10-02 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
DE19947234A1 (de) 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
KR20010089887A (ko) 1999-10-20 2001-10-12 야스이 쇼사꾸 수성의약품 조성물
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
CN1376066A (zh) 1999-11-18 2002-10-23 爱尔康公司 H1拮抗剂和安全类固醇的治疗眼病的用途
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
ATE317268T1 (de) 2001-12-05 2006-02-15 Alcon Inc Verwendung eines h1-antagonisten und von rimexolon als sicheres steroid zur behandlung von rhinitis
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2504200A1 (en) * 2002-11-12 2004-05-27 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis

Also Published As

Publication number Publication date
WO2004019955A1 (en) 2004-03-11
JP2005539044A (ja) 2005-12-22
EP2295062A1 (de) 2011-03-16
AU2003273396A1 (en) 2004-03-19
US8486923B2 (en) 2013-07-16
SI1545548T1 (sl) 2010-11-30
ES2393864T3 (es) 2012-12-28
NO335400B1 (no) 2014-12-08
CA2495830A1 (en) 2004-03-11
JP4746318B2 (ja) 2011-08-10
US20050245493A1 (en) 2005-11-03
ES2348034T3 (es) 2010-11-29
IL166483A0 (en) 2006-01-15
EP2295062B1 (de) 2012-08-29
US20110092471A1 (en) 2011-04-21
PL373433A1 (en) 2005-08-22
ZA200500719B (en) 2006-02-22
BR0313611A (pt) 2005-06-21
MXPA05001885A (es) 2005-06-03
NO20051521L (no) 2005-03-22
EP1545548B1 (de) 2010-06-30
DK1545548T3 (da) 2010-09-27
EP1545548A1 (de) 2005-06-29
KR20050058400A (ko) 2005-06-16
DE60333205D1 (de) 2010-08-12
IL166483A (en) 2013-11-28
US7879832B2 (en) 2011-02-01
NZ538954A (en) 2007-04-27
BRPI0313611B1 (pt) 2018-03-06
KR101067795B1 (ko) 2011-09-27
PT1545548E (pt) 2010-09-02
CA2495830C (en) 2012-08-21
JP2011021043A (ja) 2011-02-03
NO20051521D0 (no) 2005-03-22
AU2003273396B2 (en) 2008-12-11
CN1674916A (zh) 2005-09-28

Similar Documents

Publication Publication Date Title
DE60319865D1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
ATE439863T1 (de) Ophthalmische zusammensetzungen von parasympathischen stimulantia und entzündungshemmer zur verwendung bei der behandlung von presbyopie
ATE554756T1 (de) Kombination aus epothilon-analog und chemotherapeutika zur behandlung von proliferativen erkrankungen
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE50306850D1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
DE60238149D1 (de) Arylsulfonamid-Derivate zur Verwendung als CCR3-Antagonisten bei der Behandlung von inflammatorischen und immunologischen Erkrankungen
DE60327622D1 (de) Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien
DE602006010401D1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
DE60221627D1 (de) Thiazolderivate und ihre Verwendung zur Behandlung oder Vorbeugung von Infektionen durch Flaviviren
DE60324777D1 (de) Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE60328517D1 (de) Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
ATE427759T1 (de) Behandlung von fettsucht und verbundenen erkrankungen
DE602004010708D1 (de) Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
DE60214542D1 (de) Verwendung von cox2 inhibitoren zur behandlung von schizophrenia und des ticks
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60233740D1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
ATE362923T1 (de) 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen
ATE333452T1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderiva e und deren verwendung zur behandlung von schmerzen,angstzuständen oder erkrankungen des magen-darm- trakts
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE60217653D1 (de) Verwendung von melatonin zur behandlung der mit konzentrationsschwäche einhergehenden hyperaktivität

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1545548

Country of ref document: EP